Aayush Shah

Aayush Shah has a diverse work experience spanning multiple industries and roles. Aayush recently worked as a Business Development Manager at PQE Group, where they successfully managed market presence by establishing business relations and partnerships with top-level executives. Aayush was responsible for generating $2M worth of business for the company. Prior to that, Aayush worked as a Business Development Coordinator at the same company, where they strategized market presence and organized ongoing outreach in multiple territories.

Aayush also gained experience as a Business Development Assistant at CSSi LifeSciences, where they focused on client acquisition and international relations. Aayush networked with potential clients at partnering conferences and successfully converted 44 leads.

Additionally, Aayush worked as an Industrial and Research Intern at CoSara Diagnostics Pvt. Ltd., where they received training in industrial, research, and administrative processes. Aayush also served as a Graduate Student Researcher at UCL, conducting research on diabetic nephropathy.

Furthermore, Aayush has held leadership roles at AIESEC in United Arab Emirates and as a Public Relations Officer at the American Society for Microbiology.

Aayush Shah has a diverse educational background. Aayush obtained a Master of Science (MS) degree in Biotechnology (BioBusiness) from Georgetown University. Additionally, they earned another Master of Science (MS) degree in Nanotechnology and Regenerative Medicine from UCL. Prior to their postgraduate education, Aayush completed their Bachelor of Science (B.Sc.) in Biotechnology at Manipal Academy of Higher Education.

In terms of their earlier education, Aayush attended Nalanda International School, where they pursued Pure Science. Before that, they completed their K.G and Junior School education at Shaishav School in Vadodara.

Furthermore, Aayush Shah has also obtained an additional certification in Advanced Regulatory Compliance Training from Georgetown University Medical Center in May 2021.